X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
humans (11) 11
oncology (9) 9
prostate cancer (8) 8
urology & nephrology (8) 8
cancer (6) 6
male (6) 6
surgery (5) 5
aged (4) 4
chemotherapy (4) 4
female (4) 4
prostatic neoplasms (4) 4
research (4) 4
urology (4) 4
cancer therapies (3) 3
cardiotoxicity (3) 3
castration (3) 3
health aspects (3) 3
increased survival (3) 3
men (3) 3
middle aged (3) 3
mortality (3) 3
neoplasm metastasis (3) 3
patients (3) 3
abiraterone (2) 2
adjuvant chemotherapy (2) 2
adult (2) 2
androgen antagonists - adverse effects (2) 2
androgen deprivation (2) 2
androgen-deprivation therapy (2) 2
androgens (2) 2
antineoplastic agents - therapeutic use (2) 2
bone (2) 2
breast neoplasms - drug therapy (2) 2
care and treatment (2) 2
diagnosis (2) 2
doxorubicin (2) 2
drug therapy (2) 2
drugs (2) 2
echocardiography (2) 2
enzalutamide (2) 2
fracture (2) 2
guideline (2) 2
health risk assessment (2) 2
medicare part d (2) 2
morbidity (2) 2
oncology, experimental (2) 2
osteoporosis (2) 2
prevention (2) 2
prostate (2) 2
prostatectomy (2) 2
radiation therapy (2) 2
research article (2) 2
risk (2) 2
survival (2) 2
systolic dysfunction (2) 2
usage (2) 2
abcb1 (1) 1
abridged index medicus (1) 1
access to care (1) 1
acetate (1) 1
adoption (1) 1
aged, 80 and over (1) 1
alcohol oxidoreductases - genetics (1) 1
alfacalcidol (1) 1
american-college (1) 1
analysis (1) 1
androgen antagonists - therapeutic use (1) 1
androgen blockade (1) 1
androgen deprivation therapy (1) 1
androgen suppression (1) 1
androgen suppression therapy (1) 1
androstenes - therapeutic use (1) 1
anthracycline (1) 1
anthracyclines (1) 1
anthracyclines - adverse effects (1) 1
anti-androgen effect (1) 1
antibiotics, antineoplastic - adverse effects (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antigen (1) 1
antigens (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
anti‐androgen effect (1) 1
article (1) 1
association (1) 1
atp binding cassette transporter, sub-family b - genetics (1) 1
attitudes (1) 1
autologous hematopoietic stem cell transplant (1) 1
behavior (1) 1
behavior change (1) 1
behavior-change (1) 1
benzamides (1) 1
biochemical recurrence (1) 1
biomarker (1) 1
biomarkers (1) 1
bisphosphonates (1) 1
body-mass index (1) 1
bone cancer (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Urology, ISSN 0022-5347, 05/2018, Volume 199, Issue 5, pp. 1172 - 1173
Journal Article
The Journal of urology, 05/2018, Volume 199, Issue 5, p. 1172
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 12/2011, Volume 104, Issue 8, pp. 888 - 895
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 26, pp. 3221 - 3222
Journal Article
European Urology, ISSN 0302-2838, 02/2018, Volume 73, Issue 2, pp. 212 - 214
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2018, Volume 36, Issue 10, pp. 991 - 999
PurposeTo determine whether cotargeting poly (ADP-ribose) polymerase-1 plus androgen receptor is superior to androgen receptor inhibition in metastatic... 
POLY(ADP-RIBOSE) POLYMERASE | GENE FUSIONS | ONCOLOGY | TRANSCRIPTION | PTEN | INCREASED SURVIVAL | REARRANGEMENTS | CELL | CHEMOTHERAPY | ABIRATERONE | ENZALUTAMIDE | ORIGINAL REPORTS
Journal Article
Urology, ISSN 0090-4295, 04/2019, Volume 126, pp. 83 - 88
To evaluate the 2019 Medicare Physician Fee Schedule, which modifies reimbursement for office evaluation and management (E&M) visits. This policy moves payment... 
UROLOGY & NEPHROLOGY | GUIDELINES | Medicare | Health care reform
Journal Article
Urology Practice, ISSN 2352-0779, 09/2018, Volume 5, Issue 5, pp. 351 - 359
Introduction: Millions of patients take prescription medications each year for common urological conditions. Generic and brand-name drugs have widely divergent... 
drug costs | cost savings | prescription drugs | Medicare Part D | urology
Journal Article
Journal Article
Urology practice, ISSN 2352-0779, 07/2019, Volume 6, Issue 4, p. 234
Six treatments have improved overall survival in men with metastatic castration-resistant prostate cancer (mCRPC), each differing in toxicities and cost. This... 
Journal Article
BMC Cancer, ISSN 1471-2407, 03/2018, Volume 18, Issue 1, pp. 258 - 10
Background: Several systemic treatments have been shown to increase survival for patients with metastatic castration-resistant prostate cancer. This study... 
Novel agents | Variation | Claims data | Care delivery | Prostate cancer | FINANCIAL TOXICITY | MITOXANTRONE | CASTRATION | CHEMOTHERAPY | GUIDELINE | PREDNISONE | THERAPY | ONCOLOGY | INCREASED SURVIVAL | ENZALUTAMIDE | ABIRATERONE | Usage | Docetaxel | Prices and rates | Causes of | Dosage and administration | Research | Drug therapy
Journal Article
Journal Article
BJU International, ISSN 1464-4096, 07/2019, Volume 124, Issue 1, pp. 55 - 61
Objectives To characterise bone scan use, and potential overuse, after radical prostatectomy (RP) using data from a large, national integrated delivery system.... 
neoplasm metastasis | prostatectomy | radionuclide imaging | diagnostic imaging | prostatic neoplasms | MORTALITY | BIOCHEMICAL RECURRENCE | SCINTIGRAPHY | CANCER | FAILURE | PSMA | PROBABILITY | PET/CT | UROLOGY & NEPHROLOGY | LIGAND | ANTIGEN | Prostate cancer | Surgery | Diagnostic imaging | Radiation therapy | Health risk assessment | Cancer therapies
Journal Article
Journal Article
Urology, ISSN 0090-4295, 09/2019, Volume 131, pp. 176 - 183
OBJECTIVE To investigate the adoption of abiraterone and enzalutamide by urologists. Abiraterone and enzalutamide are oral therapies approved for the treatment... 
UROLOGY & NEPHROLOGY | INCREASED SURVIVAL | METASTATIC PROSTATE-CANCER | ATTITUDES | SURGEONS
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 70, Issue 2, pp. 209 - 210
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2015, Volume 152, Issue 1, pp. 163 - 172
Journal Article